DARAIO, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 686
EU - Europa 316
AS - Asia 254
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.268
Nazione #
US - Stati Uniti d'America 682
CN - Cina 135
IT - Italia 71
SG - Singapore 55
IE - Irlanda 53
AT - Austria 43
SE - Svezia 39
FR - Francia 36
UA - Ucraina 21
FI - Finlandia 19
VN - Vietnam 18
DE - Germania 17
IN - India 10
JP - Giappone 10
SN - Senegal 10
PL - Polonia 8
ID - Indonesia 7
HK - Hong Kong 6
KR - Corea 6
MY - Malesia 4
CR - Costa Rica 3
GB - Regno Unito 3
IQ - Iraq 3
ES - Italia 2
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
BE - Belgio 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
RO - Romania 1
Totale 1.268
Città #
Chandler 147
Beijing 88
Dublin 53
Singapore 47
Vienna 43
Nyköping 31
Ashburn 29
Fairfield 29
Torino 23
Houston 22
Villeurbanne 22
Santa Clara 19
Wilmington 18
Dearborn 17
Medford 17
Seattle 16
Princeton 15
Columbus 14
Fremont 13
Woodbridge 13
Ann Arbor 11
Dong Ket 10
Jacksonville 10
Pisa 10
Jakarta 7
San Mateo 7
Guangzhou 6
New York 6
San Jose 6
Warsaw 6
Boston 5
Chengdu 5
Norwalk 5
Washington 5
Wuhan 5
Hong Kong 4
Munich 4
Düsseldorf 3
Hefei 3
Nanchang 3
Nanjing 3
Paris 3
Redwood City 3
San José 3
Venice 3
Arbil 2
Cambridge 2
Central 2
Changsha 2
Freiburg 2
Gdynia 2
Hangzhou 2
Hebei 2
Jinan 2
Johor Bahru 2
Kunming 2
Piossasco 2
Saint-Fons 2
San Diego 2
Seoul 2
Turin 2
Upper Marlboro 2
Venezia 2
Adelaide 1
Berlin 1
Brescia 1
Brno 1
Brussels 1
Carol Stream 1
Changchun 1
Chennai 1
Costa Mesa 1
Easton 1
Falls Church 1
Fuzhou 1
Galati 1
Guiyang 1
Helsinki 1
Hyderabad 1
Kota Kinabalu 1
Montpellier 1
Mountain View 1
New Orleans 1
Ningbo 1
Palo Alto 1
Piemonte 1
Rome 1
Salt Lake City 1
Shenyang 1
Stockholm 1
Toronto 1
Valdagno 1
Verona 1
Zhengzhou 1
Totale 879
Nome #
DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION 136
CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report 131
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 123
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 115
EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS 91
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia 90
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale 85
Consistency Of RQPCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View 84
STANDARD AND HIGH SENSITIVITY MOLECULAR ANALYSIS IN CHRONIC MYELOID LEUKEMIA PATIENTS CANDIDATE TO DISCONTINUATION OF TYROSINE KINASE INHIBITORS 74
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor 71
Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients 70
One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment. 66
Treatment-free remission in chronic myeloid leukemia harboring atypical BCRABL1 transcripts 66
Second-Generation Tyrosine Kinase Inhibitors Can Induce Complete Molecular Response in Ph-Positive Acute Lymphoblastic Leukemia After Allogeneic Stem Cell Transplant 61
Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start? 61
Totale 1.324
Categoria #
all - tutte 4.347
article - articoli 0
book - libri 0
conference - conferenze 2.101
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020100 0 0 0 0 2 22 16 10 13 22 7 8
2020/2021146 10 10 3 10 14 5 15 7 7 5 25 35
2021/2022181 18 4 3 5 13 4 13 9 7 10 60 35
2022/2023340 33 35 10 41 20 84 13 22 41 18 19 4
2023/2024104 17 25 10 6 7 14 2 4 0 2 9 8
2024/2025122 0 26 16 41 39 0 0 0 0 0 0 0
Totale 1.324